Ethical Human Sciences and Services, Vol. 2, No.2, 2000 EDITORIAL
In February 2000, a research study and an editorial published in the Journal of the American Medical Association (JAMA) aroused the nation about the psychiatric medicating of very young children. The report by Maryland researchers led by Julie Zito examined prescription rates for psychiatric drugs for 2- to 4-year-old toddlers. The researchers found an average threefold increase in prescriptions of stimulant drugs, especially Ritalin® (methylphenidate), for these tiny tots from 1990 to 1995. Prescriptions for Prozac-like antidepressants had also escalated. No results were reported for post-1995, but in the current prodrug environment, prescriptions to toddlers have almost certainly continued to escalate.
Read the rest of this here: